{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T12:11:47Z","timestamp":1780920707762,"version":"3.54.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"vor","delay-in-days":78,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.ctarc.2026.101189","type":"journal-article","created":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T16:00:19Z","timestamp":1774108819000},"page":"101189","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Rethinking local therapy in de novo metastatic breast cancer: the emerging role of radiotherapy"],"prefix":"10.1016","volume":"47","author":[{"given":"Valentina","family":"Zagardo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Pontoriero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"Scandurra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2305-5544","authenticated-orcid":false,"given":"Gianluca","family":"Ferini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ctarc.2026.101189_bib0001","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.clbc.2021.01.017","article-title":"Epidemiology of De Novo metastatic breast cancer","volume":"21","author":"Daily","year":"2021","journal-title":"Clin. Breast Cancer"},{"key":"10.1016\/j.ctarc.2026.101189_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.breast.2025.104483","article-title":"Options for postoperative radiation therapy in patients with de novo metastatic breast cancer","volume":"82","author":"Li","year":"2025","journal-title":"Breast"},{"issue":"3","key":"10.1016\/j.ctarc.2026.101189_bib0003","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s10549-014-2916-8","article-title":"Treatment patterns and clinical outcomes for patients with de novo versus recurrent HER2-positive metastatic breast cancer","volume":"145","author":"Yardley","year":"2014","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.ctarc.2026.101189_bib0004","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.643155","article-title":"Role of the combination of cyclin-dependent kinase inhibitors (CDKI) and radiotherapy (RT) in the treatment of metastatic breast cancer (MBC): advantages and risks in clinical practice","volume":"11","author":"Gagliano","year":"2021","journal-title":"Front. Oncol."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101189_bib0005","doi-asserted-by":"crossref","first-page":"751","DOI":"10.3390\/cancers17050751","article-title":"Quality of life after locoregional treatment in women with de novo metastatic breast cancer: a systematic review and meta-analysis","volume":"17","author":"Weiss","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ctarc.2026.101189_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.breast.2024.103870","article-title":"Therapeutic strategies for fungating and ulcerating breast cancers: a systematic review and narrative synthesis","volume":"79","author":"Zagardo","year":"2025","journal-title":"Breast"},{"issue":"5","key":"10.1016\/j.ctarc.2026.101189_bib0007","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.21873\/invivo.13719","article-title":"The promising effects of lattice radiotherapy for large, fungating, or ulcerating breast cancers: a prospective single-center study","volume":"38","author":"Ferini","year":"2024","journal-title":"In Vivo"},{"key":"10.1016\/j.ctarc.2026.101189_bib0008","doi-asserted-by":"crossref","unstructured":"Wu C., Li X., Liu S., et al. Primary tumor resection in de novo metastatic breast cancer from an oligometastatic perspective: a systematic review and meta-analysis. IScience. 2024;27(12):111224. Published 2024 Oct 31. doi:10.1016\/j.isci.2024.111224.","DOI":"10.1016\/j.isci.2024.111224"},{"key":"10.1016\/j.ctarc.2026.101189_bib0009","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.radonc.2019.12.019","article-title":"Radiation therapy to the primary tumor for de novo metastatic breast cancer and overall survival in a retrospective multicenter cohort analysis","volume":"145","author":"Pons-Tostivint","year":"2020","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.ctarc.2026.101189_bib0010","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.736690","article-title":"Stereotactic body radiation therapy for oligometastatic breast cancer: a retrospective multicenter study","volume":"11","author":"Lemoine","year":"2021","journal-title":"Front. Oncol."},{"issue":"10","key":"10.1016\/j.ctarc.2026.101189_bib0011","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.ejso.2015.07.013","article-title":"Surgery of the primary tumor in de novo metastatic breast cancer: to do or not to do?","volume":"41","author":"Criscitiello","year":"2015","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.ctarc.2026.101189_bib0012","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1083297","article-title":"Locoregional treatment of de novo stage IV breast cancer in the era of modern oncology","volume":"13","author":"Merloni","year":"2023","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101189_bib0013","doi-asserted-by":"crossref","first-page":"220","DOI":"10.4161\/cam.20875","article-title":"Mesenchymal stem cells in tumor development: emerging roles and concepts","volume":"6","author":"Cuiffo","year":"2012","journal-title":"Cell Adh. Migr."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101189_bib0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/oncolo\/oyad266","article-title":"Impact of primary breast surgery on overall survival of patients with de novo metastatic breast cancer: a systematic review and meta-analysis","volume":"29","author":"Villacampa","year":"2024","journal-title":"Oncologist"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101189_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2023.107308","article-title":"Breast surgery for patients with de novo metastatic breast cancer: a meta-analysis of randomized controlled trials","volume":"50","author":"Ren","year":"2024","journal-title":"Eur. J. Surg. Oncol."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101189_bib0016","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s10549-023-07116-6","article-title":"Surgery of the primary tumor in patients with de novo metastatic breast cancer: a nationwide population-based retrospective cohort study in Belgium","volume":"203","author":"Brand\u00e3o","year":"2024","journal-title":"Breast Cancer Res. Treat."},{"issue":"9","key":"10.1016\/j.ctarc.2026.101189_bib0017","doi-asserted-by":"crossref","first-page":"5048","DOI":"10.1245\/s10434-021-09621-8","article-title":"The effect of primary surgery in patients with de novo stage IV breast cancer with bone metastasis only (Protocol BOMET MF 14-01): a multi-center, prospective registry study","volume":"28","author":"Soran","year":"2021","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.ctarc.2026.101189_bib0018","doi-asserted-by":"crossref","unstructured":"King T.A., Lyman J.P., Gonen M., Voci A., De Brot M., Boafo C., Sing A.P., Hwang E.S., Alvarado M.D., Liu M.C., Boughey J.C., McGuire K.P., Van Poznak C.H., Jacobs L.K., Meszoely I.M., Krontiras H., Babiera G.V., Norton L., Morrow M., Hudis C.A. A prospective analysis of surgery and survival in stage IV breast cancer (TBCRC 013). DOI: 10.1200\/JCO.2016.34.15_suppl.1006.","DOI":"10.1200\/JCO.2016.34.15_suppl.1006"},{"issue":"13","key":"10.1016\/j.ctarc.2026.101189_bib0019","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/S1470-2045(15)00135-7","article-title":"Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: an open-label randomised controlled trial","volume":"16","author":"Badwe","year":"2015","journal-title":"Lancet Oncol."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101189_bib0020","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1097\/SLA.0000000000002771","article-title":"ABCSG. Impact of breast surgery in primary metastasized breast cancer: outcomes of the prospective randomized phase III ABCSG-28 POSYTIVE trial","volume":"269","author":"Fitzal","year":"2019","journal-title":"Ann Surg."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101189_bib0021","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.jamcollsurg.2021.08.686","article-title":"MF07-01 Study group. Primary surgery with systemic therapy in patients with de novo stage IV breast cancer: 10-year follow-up; protocol MF07-01 randomized clinical trial","volume":"233","author":"Soran","year":"2021","journal-title":"J. Am. Coll. Surg."},{"issue":"9","key":"10.1016\/j.ctarc.2026.101189_bib0022","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1200\/JCO.21.02006","article-title":"Early local therapy for the primary site in De Novo stage IV breast cancer: results of a randomized clinical trial (EA2108)","volume":"40","author":"Khan","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101189_bib0023","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s12282-011-0276-3","article-title":"Improvement of survival and prospect of cure in patients with metastatic breast cancer","volume":"19","author":"Cheng","year":"2012","journal-title":"Breast Cancer"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101189_bib0024","article-title":"Development and validation of nomograms for predicting survival in patients with de novo metastatic triple-negative breast cancer","volume":"12","author":"Chen","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ctarc.2026.101189_bib0025","doi-asserted-by":"crossref","DOI":"10.1177\/15330338251341195","article-title":"Survival impact of postoperative primary area radiotherapy on De Novo metastatic breast cancer: a retrospective study","volume":"24","author":"Li","year":"2025","journal-title":"Technol. Cancer Res. Treat."},{"key":"10.1016\/j.ctarc.2026.101189_bib0026","doi-asserted-by":"crossref","DOI":"10.1177\/03008916251386980","article-title":"Postoperative radiotherapy for stage IV breast cancer following primary tumor removal: systematic review and meta-analysis","author":"Merlotti","year":"2025","journal-title":"Tumori"},{"key":"10.1016\/j.ctarc.2026.101189_bib0027","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.breast.2016.05.001","article-title":"Effects of locoregional radiotherapy in patients with metastatic breast cancer","volume":"28","author":"Mauro","year":"2016","journal-title":"Breast"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101189_bib0028","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s12672-024-01360-y","article-title":"Effectiveness of radiotherapy in delaying treatment changes in primary or secondary immunorefractory oligoprogressive patients: preliminary results from a single-center study","volume":"15","author":"Zagardo","year":"2024","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.ctarc.2026.101189_bib0029","article-title":"Trastuzumab deruxtecan in HER2-low metastatic breast cancer: long-term survival analysis of the randomized, phase 3 DESTINY-Breast04 trial","volume":"8","author":"Modi","year":"2025","journal-title":"Nat. Med. Published online October"},{"key":"10.1016\/j.ctarc.2026.101189_bib0030","article-title":"Systemic treatment of patients with metastatic breast cancer: ASCO resource-stratified guideline","volume":"10","author":"Al Sukhun","year":"2024","journal-title":"JCO Glob. Oncol."},{"issue":"10237","key":"10.1016\/j.ctarc.2026.101189_bib0031","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0140-6736(20)30932-6","article-title":"Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial","volume":"395","author":"Murray Brunt","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ctarc.2026.101189_bib0032","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.bjps.2025.08.042","article-title":"Breast reduction and mastopexy procedures on previously irradiated breasts: a retrospective study","volume":"110","author":"Bissar","year":"2025","journal-title":"J. Plast. Reconstr. Aesthet. Surg."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101189_bib0033","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/jnci\/djx148","article-title":"Impact of radiotherapy on complications and patient-reported outcomes after breast reconstruction","volume":"110","author":"Jagsi","year":"2018","journal-title":"J. Natl Cancer Inst."},{"key":"10.1016\/j.ctarc.2026.101189_bib0034","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.91737","article-title":"Northeastern Clinical Research Alliance of Oncology (NCRAO). Effects of neoadjuvant stereotactic body radiotherapy plus adebrelimab and chemotherapy for triple-negative breast cancer: a pilot study","volume":"12","author":"Chen","year":"2023","journal-title":"Elife"},{"key":"10.1016\/j.ctarc.2026.101189_bib0035","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.radonc.2021.09.031","article-title":"Stereotactic body radiotherapy to treat breast cancer oligometastases: a systematic review with meta-analysis","volume":"164","author":"Viani","year":"2021","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.ctarc.2026.101189_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110240","article-title":"Definitive results of a prospective non-randomized phase 2 study on stereotactic body radiation therapy (sbrt) for medically inoperable lung and liver oligometastases from breast cancer","volume":"195","author":"Franceschini","year":"2024","journal-title":"Radiother. Oncol."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101189_bib0037","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.breast.2011.06.005","article-title":"Removal of primary tumor improves survival in metastatic breast cancer. Does timing of surgery influence outcomes?","volume":"20","author":"P\u00e9rez-Fidalgo","year":"2011","journal-title":"Breast"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101189_bib0038","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-75119-0","article-title":"Role of locoregional surgery in patients with de novo stage IV breast cancer: analysis of real-world data from China","volume":"10","author":"Ma","year":"2020","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.ctarc.2026.101189_bib0039","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.annonc.2021.09.019","article-title":"ESMO Guidelines Committee. Electronic address: clinicalguidelines @ esmo.Org. ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer","volume":"32","author":"Gennari","year":"2021","journal-title":"Ann. Oncol."}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226001000?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226001000?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T11:48:59Z","timestamp":1780919339000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294226001000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":39,"alternative-id":["S2468294226001000"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101189","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rethinking local therapy in de novo metastatic breast cancer: the emerging role of radiotherapy","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101189","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101189"}}